Concord Health Partners

Concord Health Partners (“Concord”) is a healthcare focused investment firm with a strategic model that optimizes the alignment of interests between investors and portfolio companies. Concord is primarily focused on investing in healthcare companies that have the potential to enhance the value of care through products, services, technologies and solutions that lower costs, improve quality and/or expand access to care.

Mike Ambrosia

Vice President

Emily Carbone

Associate

George Hoffmann

VP

Kevin Hueber

Vice President

Benson Jose

Partner/COO/CFO

Timothy Leahy

Partner

James T. Olsen

Founder and Managing Partner

Joseph Swedish

Partner Emeritus

16 past transactions

Accelus

Series D in 2022
Accelus is committed to accelerating minimally invasive spine surgery through its procedure-enabling technology with broad accessibility to previously underserved markets.

Iris Telehealth

Series B in 2022
Iris Telehealth is a leading provider of telepsychiatry services for community mental health centers, community health centers, hospitals, and health systems across the U.S.

Post Acute Analytics

Series C in 2022
Post Acute Analytics, Inc. develops solutions for real-time tracking of patients across the continuum of care. It offers Continuum of Care Suite, which include Total Patient Tracker to know where the patients are and how they are doing anywhere in the post-acute care continuum with real time, actionable data; and Care Pathway Agent to auto-create care pathways for patients, as well as to track their progress throughout the acute and post-acute journey. The company also provides Partner Monitor that enables teams to have data-driven discussions based on analytics and facts that ensure the patient outcome is consistently positive. The company was incorporated in 2018 and is based in Lewisville, Texas.

MindMaze

Venture Round in 2022
MindMaze is a company focused on developing medical-grade virtual reality products aimed at stimulating neural recovery. Founded in 2012 and headquartered in Lausanne, Switzerland, with additional locations in Zürich, Ecublens, and San Francisco, MindMaze offers a platform that integrates virtual reality, computer graphics, brain imaging, and neuroscience. Its flagship product, MindMotionPRO, provides engaging virtual reality rehabilitation programs tailored to individual patient needs, allowing clinicians to personalize therapy modalities and optimize rehabilitation delivery in hospital settings. The company's technology encompasses lightweight wearable head-mounted displays, 3D motion capture cameras, and advanced user interfaces, enabling capabilities in gesture recognition and augmented reality. MindMaze also invests in motion capture technology, immersive virtual reality experiences, and neurophysiological measurements, positioning itself at the intersection of gaming, brain-machine control, and healthcare.

Cyglera

Series A in 2021
Our mission at Cylera is to protect healthcare organizations and their patients from those who wish to do them harm. Enabled by our breakthrough technology, we take a patient-centric approach to defend and optimize all of the devices that healthcare providers rely on to provide care including medical devices, operational technology, and enterprise IoT, so that together we can safeguard what matters most.

Clarify Health Solutions

Series C in 2021
Clarify Health Solutions, Inc. operates a data-driven platform designed to enhance patient care by providing real-time insights to patients, clinicians, and care managers. The platform, known as Clarify Episode, facilitates the optimization of care episodes by stratifying patients based on various characteristics and monitoring their progress to detect potential complications early. Key offerings include Care Pilot, a mobile and web-based tool that empowers patients in their care journey; Care Connect, which allows clinicians to monitor and intervene as needed; and Care Prism, which delivers real-time analytics for management. The solutions aim to improve efficiency and personalization in healthcare delivery, enabling health systems to streamline workflows and focus on patients with the greatest needs. Founded in 2015 and headquartered in San Francisco, the company also offers data analytics and change management solutions, forming strategic alliances to enhance its impact in the healthcare sector.

Cedar

Series D in 2021
Cedar is a patient payment and engagement platform for hospitals, health systems, and medical groups that elevate the end-to-end patient experience. The platform leverages advanced data science to customize and simplify the payment experience, resulting in a modern, consumer-friendly way for patients to plan for and pay their bills. It was founded in 2016 and is headquartered in New York, New York.

Post Acute Analytics

Series B in 2021
Post Acute Analytics, Inc. develops solutions for real-time tracking of patients across the continuum of care. It offers Continuum of Care Suite, which include Total Patient Tracker to know where the patients are and how they are doing anywhere in the post-acute care continuum with real time, actionable data; and Care Pathway Agent to auto-create care pathways for patients, as well as to track their progress throughout the acute and post-acute journey. The company also provides Partner Monitor that enables teams to have data-driven discussions based on analytics and facts that ensure the patient outcome is consistently positive. The company was incorporated in 2018 and is based in Lewisville, Texas.

MIVI Neuroscience

Series B in 2021
MIVI Neuroscience, Inc. is a medical device company based in Eden Prairie, Minnesota, that specializes in developing and commercializing innovative solutions for neurointerventional procedures. Founded in 2013, the company offers a range of products designed to enhance patient outcomes, including high flow tubing, diagnostic catheters, guide catheters, distal access catheters, and aspiration pumps. MIVI's offerings also feature embolic protection and clot retrieval devices, along with advanced catheter systems aimed at removing obstructions and restoring blood flow for patients suffering from ischemic stroke. By focusing on reducing complications and procedure times, MIVI Neuroscience seeks to expand treatment options for a broader patient population.

Loyal

Series A in 2020
Loyal Health, Inc. specializes in artificial intelligence-based software solutions designed for health systems and hospitals. The company offers a range of products including a healthcare data management platform named Connect, a physician search solution called Patient Connect, an intuitive directory management tool known as Directory Connect, and Guide, which features both conversational AI and live chat capabilities. Additionally, Loyal provides Empower, a platform dedicated to physician ratings and reviews. Established in 2015 and based in Atlanta, Georgia, Loyal focuses on enhancing patient engagement and loyalty by utilizing AI to improve the digital patient experience and facilitate meaningful feedback collection. Through partnerships with leading health systems, Loyal aims to streamline patient interactions and enrich data management in the healthcare sector.

Bright.md

Series C in 2020
Bright.md is a developer of an AI-powered virtual-care platform designed to modernize direct-to-patient telehealth for healthcare systems. The company partners with premier healthcare organizations to offer SmartExam to more than 10 million patients who are seeking convenient urgent and primary care online, connecting them to their physicians via a home computer or mobile device reducing visits, enabling patients to receive conveniently, high quality, asynchronous, online care from established and trusted health system providers. The company was founded in 2014 and is based in Portland, Oregon.

Pieces

Series B in 2020
Pieces Technologies, Inc. is a healthcare software solutions company founded in 2015 and headquartered in Dallas, Texas. The company emerged from the work of its founder, Ruben Amarasingham, MD, at Parkland Health & Hospital System, where he developed predictive models aimed at reducing patient readmissions. This initiative led to the establishment of the non-profit research institute PCCI, which has garnered over $50 million in scientific funding. Pieces Technologies functions as a dynamic center for innovation, addressing healthcare challenges for organizations worldwide by leveraging advanced predictive analytics and technology.

CI Security

Series B in 2019
CI Security, formerly known as M. K. Hamilton & Associates, Inc., is a cybersecurity company founded in 2011 and based in Bremerton, Washington. It specializes in providing managed detection and response services, vulnerability detection, and cybersecurity consulting to safeguard critical systems across sectors such as healthcare, public services, education, and law firms. CI Security's flagship offering, Critical Insight, is a Cybersecurity-as-a-Service solution that collects and analyzes network traffic to identify potential threats through advanced detection analytics. The company also offers a range of consulting services, including technical security assessments, risk management, compliance with regulations, incident response, and digital forensics. By focusing on the protection of life-sustaining and quality-of-life systems, CI Security aims to enhance the security, compliance, and resilience of its clients against evolving cyber threats.

Mednition

Series A in 2019
Mednition offers a machine learning-powered decision support solution for hospitals. It provides real-time analytics solutions to the Health Care community and brings together health care information and machine learning to improve patient outcomes, lower risk, and reduce costs for health care providers.The company is dedicated to helping clinical and hospital operations leaders quickly and clearly see the impact of care decisions on individuals and populations and nd across healthcare systems. Mednition was founded in 2014 and is headquartered in Burlingame, California.

VitalTech

Series A in 2019
At VitalTech, we develop technologies that empower patients to better care for their safety, health, and wellness. We arm companies with the tools to improve health and wellness, foster independence and enrich relationships. VitalTech began as a biosensor technology company and has expanded to development of VitalCare, their integrated digital health platform. VitalCare simplifies workflows and supports connected care through remote patient monitoring.

MIVI Neuroscience

Venture Round in 2019
MIVI Neuroscience, Inc. is a medical device company based in Eden Prairie, Minnesota, that specializes in developing and commercializing innovative solutions for neurointerventional procedures. Founded in 2013, the company offers a range of products designed to enhance patient outcomes, including high flow tubing, diagnostic catheters, guide catheters, distal access catheters, and aspiration pumps. MIVI's offerings also feature embolic protection and clot retrieval devices, along with advanced catheter systems aimed at removing obstructions and restoring blood flow for patients suffering from ischemic stroke. By focusing on reducing complications and procedure times, MIVI Neuroscience seeks to expand treatment options for a broader patient population.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.